Actuate Therapeutics Files 8-K
Ticker: ACTU · Form: 8-K · Filed: Jun 5, 2025 · CIK: 1652935
| Field | Detail |
|---|---|
| Company | Actuate Therapeutics, Inc. (ACTU) |
| Form Type | 8-K |
| Filed Date | Jun 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, financials
TL;DR
Actuate Therapeutics filed an 8-K for Reg FD and financials.
AI Summary
Actuate Therapeutics, Inc. filed an 8-K on June 5, 2025, reporting events as of May 31, 2025. The filing primarily concerns Regulation FD disclosures and the submission of financial statements and exhibits. The company, formerly known as Apotheca Therapeutics, Inc., is incorporated in Delaware and headquartered in Fort Worth, Texas.
Why It Matters
This 8-K filing indicates Actuate Therapeutics is providing updates on its regulatory disclosures and financial reporting, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial statements and exhibits, not indicating any immediate material changes or risks.
Key Players & Entities
- Actuate Therapeutics, Inc. (company) — Registrant
- May 31, 2025 (date) — Earliest event reported
- June 5, 2025 (date) — Filing date
- Apotheca Therapeutics, Inc. (company) — Former company name
- Fort Worth, Texas (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
What was Actuate Therapeutics, Inc. formerly known as?
Actuate Therapeutics, Inc. was formerly known as Apotheca Therapeutics, Inc.
When was the earliest event reported in this filing?
The earliest event reported in this filing was as of May 31, 2025.
Where are Actuate Therapeutics, Inc.'s principal executive offices located?
Actuate Therapeutics, Inc.'s principal executive offices are located at 1751 River Run, Suite 400, Fort Worth, Texas 76107.
What is the Commission File Number for Actuate Therapeutics, Inc.?
The Commission File Number for Actuate Therapeutics, Inc. is 001-42139.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 5, 2025 regarding ACTUATE THERAPEUTICS, INC. (ACTU).